Bio-Rad Laboratories ddPLEX ESR1 Mutation Detection Kit

Thursday, 11 April, 2024 | Supplied by: Bio-Rad Laboratories Pty Ltd


Bio-Rad Laboratories has launched the ddPLEX ESR1 Mutation Detection Kit, an ultrasensitive multiplexed digital PCR assay. The assay expands the company’s Droplet Digital PCR (ddPCR) offering for the oncology market, where highly sensitive and multiplexed mutation detection assays aid translational research, therapy selection and disease monitoring.

The kit enables simultaneous detection, discrimination and absolute quantification of seven known relevant ESR1 mutations in a single well, with an analytical sensitivity down to 0.01% variant allele fraction (VAF). It includes controls and enables same-day results from either circulating tumour DNA (ctDNA) from plasma or DNA from formalin-fixed paraffin-embedded (FFPE) tissue samples.

The research-use assay is developed for Bio-Rad’s QX600 Droplet Digital PCR System, which brings advanced multiplexing and high sensitivity to a simple workflow with powerful data analysis. The assay is also the first to license NuProbe’s allele enrichment technology, announced by the two companies in 2022.

Online: www.bio-rad.com
Phone: 02 9914 2800
Related Products

Bio-Rad Laboratories Vericheck ddPCR Empty-Full Capsid Kits for AAV serotypes 2 and 8

Bio-Rad Laboratories has launched its Vericheck ddPCR Empty-Full Capsid Kits for adeno-associated...

Lumiprobe SynaptoProbe Red dye for visualising synaptic vesicles in living neurons

Lumiprobe's SynaptoProbe Red is an analogue of FM 4-64, a widely used red fluorescent dye for...

Parse Biosciences Evercode Low Input Fixation kits for cells and nuclei

The kits empower researchers who have a small number of starting cells or nuclei who ordinarily...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd